A retrospective cohort study: 10-year trend of disease-modifying antirheumatic drugs and biological agents use in patients with rheumatoid arthritis at Veteran Affairs Medical Centers [PDF]
, 2013 Bernard Ng, Adeline Chu, Myrna M. Khan
openalex +1 more source
Macrophage activation syndrome complicating adult-onset Still's disease: the case for standardized guidelines. [PDF]
Proc (Bayl Univ Med Cent)Vaseer S.
europepmc +1 more source
Further Evidence for Influenza and Pneumococcal Vaccination in Patients Treated with Disease Modifying Antirheumatic Drugs and Anti-Tumor Necrosis Factor Agents [PDF]
, 2014 Meliha C Kapetanovic
openalex +1 more source
Risk Factors for Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis: The Protective Potential of Salazosulfapyridine. [PDF]
Int J Rheum DisHara Y +7 more
europepmc +1 more source
Pharmacokinetics of Carfenil, an antirheumatic agent in patients with renal insufficiency.
, 1988 Akira Okazaki
openalex +2 more sources
Impact of Biologic Drugs on Comorbidity Outcomes in Rheumatoid Arthritis: A Systematic Review. [PDF]
J Clin MedBoussaid S +12 more
europepmc +1 more source
Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. [PDF]
, 1992 Jean D. Sipe, Laura M. Bartle, L D Loose
openalex +1 more source
The use of combinations of disease‐modifying antirheumatic agents in rheumatoid arthritis [PDF]
Arthritis & Rheumatism, 1990 openaire +3 more sources
Real world efficacy safety and drug survival of secukinumab over 6 years at the largest biological center in Poland. [PDF]
Sci RepFelis-Giemza A +7 more
europepmc +1 more source
Health economic evaluation of self-injection of biologics in patients with rheumatoid arthritis using a Japanese real-world web-based survey. [PDF]
BMC Health Serv ResTakahata K +4 more
europepmc +1 more source